WithdrawnNCT05991232
Repeated Neurocognitive Measurements in Depressed Patients
Medication studyAges 18–60United StatesDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 60 years.
- Listed locations
- ColumbusSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 1, 2025
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Jay Fournier
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT05991232
- Official title
Show the full official title
Repeated Neurocognitive Measurements in Depressed Patients
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Columbus
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Jay Fournier.
Does this study involve medication?
Yes. The study involves medication, including Intravenous Ketamine.
Who can participate?
Listed age limits: 18 years to 60 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
